<DOC>
	<DOCNO>NCT01093677</DOCNO>
	<brief_summary>LIM-0705 gain result effect LIM-0705 Male Subjects Impaired Glucose Tolerance</brief_summary>
	<brief_title>Investigation Safety , Tolerability , Pharmacokinetics , Pharmacodynamics LIM-0705 Male Subjects With Impaired Glucose Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>1 . Males , age 1870 year old 2 . Measured waist circumference hip circumference ratio &gt; 0.90 3 . Body mass index ( BMI ) 27 40 kg/m2 4 . Screening Day 1 capillary glucose measurement 110160 mg/dL ( 6.18.9 mmol/L ) 12 hour fast 5 . Screening Day 1 OGTT 2 hour postglucose measurement ≥140 mg/dL ( 7.8 mmol/L ) 12 hour fast 6 . Screening HbA1c &gt; 6 ≤ 7.5 % 7 . Subjects must reasonably good health determine prestudy medical history , physical examination , 12lead ECG , follow laboratory measure : Electrolytes , ALP , LDH , creatinine , urea must within normal range without medication Urinalysis within normal limit 8 . Willing remain confinement clinical study unit 18 days/17 night return unit specify additional assessment 9 . Willing consume food provide clinical study unit 10 . Nonsmokers `` social smoker '' ( define few 5 cigarette per week ) willing abstain smoking duration study 11 . Willing abstain alcoholcontaining , grapefruitcontaining , caffeinecontaining food beverages 12 . Able read , understand follow study instruction 13 . Agree use two effective method contraception 1 . Allergy onion red wine 2 . Strict vegetarian ( i.e. , subject eat meat , fish , fowl , dairy ) 3 . Use nonstudy medication ( ) study period approve Investigator treatment adverse event ( AE ) 4 . Use chemotherapy agent history cancer , nonmetastatic nonmelanoma skin cancer completely excise , within five ( 5 ) year prior Screening visit 5 . Use dietary aid food know modulate drug metabolize enzyme ( e.g. , St. John 's Wort , grapefruit juice ) within 4 day randomization 6 . History bacterial viral infection require treatment antibiotic antiviral within 30 day randomization 7 . Difficulty swallow oral medication 8 . History seizure disorder 9 . Moderate severe gastroesophageal reflux disease 10 . History arrhythmia 11 . Cognitive psychiatric disorder , condition could interfere compliance study procedure and/or confinement clinical study unit 12 . Baseline liver enzymes great upper limit normal 13 . Baseline creatine phosphokinase ( CPK ) great 2.5x upper limit normal 14 . History drug alcohol abuse 15 . Use investigational drug within 30 day randomization investigational biologic within 180 day randomization 16 . Use overthecounter ( OTC ) medication nutraceuticals , exclude routine vitamin , within 14 day randomization 5 halflives drug , whichever longer 17 . Use prescription pharmaceutical within 30 day randomization 18 . Donation and/or receipt blood blood product within 90 day randomization 19 . Current gastrointestinal ( GI ) , renal , hepatic , coagulant disorder within 12 month randomization 20 . History peptic duodenal ulcer GI bleed 21 . Subjects Gilbert 's Syndrome 22 . Subjects positive drug alcohol screen 23 . Subject positive hepatitis C antibody ( HCV ) , hepatitis B surface antigen ( HBsAg ) , human immunodeficiency virus ( HIV ) antibody</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>